Peer-reviewed veterinary case report
Primary heart cancer in older Golden Retrievers and other dogs
By Yamamoto, Shinya et al.·Published in The Journal of veterinary medical science·2013·Tokyo University of Agriculture and Technology, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Epidemiological, clinical and pathological features of primary cardiac hemangiosarcoma in dogs: a review of 51 cases.
- Species:
- dog
Plain-English summary
A group of 51 dogs diagnosed with primary cardiac hemangiosarcoma (a type of cancer affecting the heart) showed that older Golden Retrievers, Maltese, and Miniature Dachshunds were most commonly affected. Many of these tumors were found in the right atrium or right auricle of the heart, with larger masses being more easily detected in the right atrium. Dogs that underwent surgery followed by chemotherapy lived significantly longer than those who only had surgery. This suggests that adding chemotherapy after surgery could improve survival for dogs with this serious condition.
People also search for: dog heart cancer treatment · Golden Retriever cardiac hemangiosarcoma · chemotherapy for dog tumors
Abstract
In the study presented here, we aimed to describe the epidemiological, clinical and pathological findings of 51 canine cases with histologically-verified diagnoses of primary cardiac hemangiosarcoma (HSA). The medical data for each dog, including signalment, presenting complaints, physical examination findings, results of various diagnostic testing performed and method of treatment, were checked. In addition, all 51 cases were re-examined pathologically. The tumor occurred most frequently in older Golden Retrievers, followed by Maltese dogs and Miniature Dachshunds. Mass lesions of HSA were found more commonly in the right auricle (RAu) (25/51) and right atrium (RA) (21/51), and the RA masses were significantly (P<0.001) larger than the RAu masses. The echocardiographic detection rate of masses in the RAu group (60%; 15/25) was significantly lower than that in the RA group (95%; 20/21). Survival time was significantly (P<0.05) longer for 5 dogs that received adjuvant chemotherapy after tumor resection than for 12 dogs that did not. In this series, the Maltese (9/51) and Miniature Dachshund (7/51), as well as the Golden Retriever, were represented more frequently than other breeds. The lower echocardiographic detection rate of RAu masses compared with RA masses may be related to tumor size and/or location. The significantly longer survival time for dogs receiving adjuvant chemotherapy indicates that postoperative chemotherapy could be useful for dogs with cardiac HSA.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/23811814/